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ABSTRACT
The first hour following a major trauma with massive bleeding is certainly the most decisive
period in global trauma care. Most of it takes place during the prehospital care. Those preho-
spital minutes are thus determinant as they can be used to correctly identified patient’s clin-
ical condition, initiate organization of the in-hospital needed resources and initiate specific
therapies in the very early phase after trauma. Significant recent advances in this aspect of




The management of severe trauma patients is one
of the biggest challenges that prehospital care pro-
viders can face. A meta-analysis of United States
trauma centers demonstrated average prehospital
times from injury to hospital admission about
30min for road ambulances and over 60min for
helicopter transports.[1] Most of the ‘‘golden-hour’’
thus sometimes takes place during the prehospital
care, making this phase of care essential.[2]
Prehospital delay, however, varies depending on
geographical situation (urban versus rural areas) and
depending of the local health system. Prehospital
delays are shorter in Europe and in our country.
For the past years, several approaches have
been proposed in order to increase the quality of
care. A large part of the care concerns evacuation
of the patient, their extraction from a vehicle, man-
agement of cervical spine immobilization, airway
management, and other topics that would not be
discussed here.
We will focus on the management of the mas-
sively bleeding trauma patients and on the many
significant recent advances in this aspect of care.
Historically, several strategies have been proposed
and used for prehospital management of massively
bleeding trauma patients. Many of those have been
developed in the military setting and adapted in
civilian trauma centers. They all aim to help the
prehospital caregivers to face this life-threatening
situation with very high mortality.
We should scoop and run. . .
In most cases of massive exsanguination, emergent
open or endovascular procedures are necessary for
hemostasis such that this cannot be achieved any-
where else but at the hospital. For this group of
patients, minimizing prehospital time and ensuring
rapid transport to the nearest facility is life-saving.
However, not all facilities provide the technology,
human resources, training, and expertise to per-
form the necessary procedures. Designation of
receiving hospitals within regional trauma systems
has been clearly demonstrated to have a positive
impact on patient mortality and morbidity.[3,4]
Thus, it is important that the patient be transported
to the appropriate facility to ensure the best out-
come, even if it is not the nearest.
We should stay and play. . .
Advanced Life Support (ALS) trained providers are
capable of performing more invasive procedures
than Basic Life Support (BLS) providers which, on
the face of it, would seem beneficial in the care of
critically injured patients. However, several studies
have shown that, in certain settings, this seems to
have little impact on patients’ outcome. Liberman
et al. [5] showed, in their multicenter Canadian
study, that there was no benefit in having on-site
ALS providers in urban areas with level-one trauma
centers. Seamon et al. [6] demonstrated the same
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results for the management of penetrating trauma
patients in an urban area with short transport times
(global prehospital time was the same for BLS or
ALS but ALS interventions did not improve patients’
outcome). Other studies in other context clearly
demonstrated better outcome with ALS.[7] ALS and
BLS are part of a global prehospital system and
their impact cannot be analyzed without their
context.
We should treat as we go. . .
Another approach to prehospital care is the ‘‘treat
as you go’’ philosophy described in the Prehospital
Trauma Life Support PHTLS manual.[8] In the pres-
ence of a severely injured trauma patient, prehospi-
tal care givers are admonished to only perform life-
saving emergent procedures, such as securing an
airway, providing oxygen, needle decompression of
tension pneumothorax, cervical spine immobiliza-
tion, pelvic binding, and splinting of extremities,
and try to do them without delaying transportation
to the hospital by performing a rapid on-site clin-
ical evaluation and then performing those thera-
peutic actions during transportation whenever
possible.
We should give fluids. . .
Massively bleeding patients suffer from hypovol-
emic shock that, if left uncorrected for too long,
will become irreversible. Early and aggressive fluid
resuscitation using crystalloids solution was the
preferred first step in the management dating back
to World War II. Significant improvements in triage
and battlefield transport during the Vietnam War
meant that more severe injuries were being treated
and transported than ever before. This also meant
that casualties were receiving large amounts of
crystalloids during the first hours of care and, when
compared with previous conflicts, it was clear that
many lives were saved from lethal hypovolemia
with aggressive fluid resuscitation. At the same
time, an interesting clinical phenomenon was first
described and was initially referred to as Da-Nang
Lung, named for the military base where these cas-
ualties were collected prior to transfer to tertiary
care centers outside the theatre of war. These were
patients who, despite having suffered no pulmon-
ary or thoracic injury, rapidly developed severe
acute respiratory distress within the first few days
of care.[9] This pulmonary edema was suspected to
be the result of alveolar lesions caused by explosive
shock waves but some recognized the possibility
that this was related to volume overload due to the
unrestrictive fluid therapy.
Other adverse effects of intravenous fluid ther-
apy are the dilution of coagulation factors that
have been lost during exsanguination and that
have a predictably negative impact on coagulation.
This effect has been demonstrated in vitro as well
as in vivo.[10,11] Additionally, unless appropriately
warmed, large infusions of fluid will profoundly
exacerbate the hypothermia that is present in
many trauma patients and, thus, plays a pivotal
role in what was called the ‘‘lethal triad’’: the triple
association of acidosis, hypothermia, and coagulop-
athy which was pointed out as having a significant
negative impact on patients’ survival after severe
trauma.[11]
We should restrict our fluid therapy. . .
Restriction of fluid resuscitation implies recognition
of the negative consequences of fluid therapy and
the need to minimize these in the process of caring
for the severely injured. This has led to the devel-
opment of what is called damage control resuscita-
tion, or the idea that early treatment of patients
massively exsanguinating should revolve around
three things: limiting the use of crystalloids, liberal
use of blood products in an equivalent ratio of
blood and plasma, and allowing for permissive
hypotension until definitive surgical hemostasis can
be achieved.[12,13] This strategy was first postu-
lated by the father of modern resuscitation, the
great American physiologist Walter Cannon as far
back as 1910 and has been relatively ignored for
nearly a century.[14] It should be noted that per-
missive hypotension should not be utilized in the
setting of known or suspected traumatic brain
injury (TBI) to avoid secondary brain injury due to
hypoperfusion.
We should stop the bleeding. . .
The treatment of bleeding is to stop the bleeding.
Trauma patients in need of emergency surgery for
ongoing hemorrhage have increased survival if the
elapsed time between injury and admission to the
operating theatre is minimized.[15] Some haemo-
static procedures might be indicated during the
prehospital stage before or during transportation
to the hospital. Clearly, any severe external bleed-
ing source can and should be controlled with either
point-pressure or tourniquet placement immedi-
ately. Unstable pelvic ring fracture should lead to
minimized mobilization and external stabilization























using sheets or pelvic sling. Pelvic ring fractures
with hemodynamic compromise sometimes need
an invasive control of the internal bleeding. This
can be accomplished within the hospital with inter-
ventional radiology.
We should transfuse the patient with blood
products in the hospital. . .
Every massively bleeding patient requires transfu-
sion of blood components, including packed red
blood cells (PRBC), plasma, and platelets. Although
the ideal ratio of components is still under debate,
balanced transfusion therapy is inarguably the
cornerstone of resuscitation in massive exsanguin-
ation. As an emergent transfusion of sufficient
blood components requires an appropriate infra-
structure and time for preparation, prehospital
caregivers should transport patient towards an
appropriate facility. In-hospital transfusion team
could be alerted before patient’s admission using
prehospital clinical judgment from care givers or
using prehospital-specific scoring systems like the
Coagulopathy of Severe Trauma score COAST or
the Trauma Induced Coagulopathy Clinical Score
TICCS, developed to identify trauma patients suffer-
ing from massive bleeding and in need for transfu-
sion.[16,17] Identification of patients in need for
massive transfusion is critical because it cannot be
applied to patients with moderate bleeding as it
will have a negative impact with higher risk for
infections, for thromboembolic events or for spe-
cific respiratory failures like Transfusion Related
Acute lung Injury or Transfusion Associated Cardiac
Overload.
We should transfuse the patient with blood
products during transportation. . .
Recent data suggest that despite our efforts, in the
context of level-one trauma centers areas with in-
hospital emergent surgery and massive transfusion
of blood products, we still are partly ineffective on
correction of both hypoperfusion and coagulop-
athy.[18] We know that the early acute coagulop-
athy starts shortly after trauma.[19] We know that
massive bleeding quickly leads to hypoperfusion
and shock. Does it mean that we should transfuse
earlier, by carrying blood products in the prehospi-
tal setting? Recent experiences in the military and
the civilian settings concerning PRBC prehospital
transfusion highlighted the feasibility of such a
practice and its potential positive impact.[20–22]
The on-going PAMPER trial (Prehospital Air Medical
Plasma Trial) will determine the effect of the preho-
spital infusion during air transport of 2 units of
plasma on 30 d mortality in patients with hemor-
rhagic shock as compared with conventional
care.[23] Previous studies emphasized the positive
impact of an early plasma transfusion in massive
hemorrhage.[24] Prehospital transfusion, however,
needs to be considered in the global context of
care and would be, thus, more interesting and rural
areas with delayed prehospital time, rather than in
urban Belgian areas with short delay before hos-
pital admission.
We should detect early acute coagulopathy. . .
As the early acute coagulopathy of trauma begins
in the very early phase after severe trauma,[19] an
early detection of this coagulopathy is needed and
could lead to potential therapeutic actions to treat
it, especially when prehospital delays are pro-
longed. Careful selection of trauma patients suffer-
ing from severe bleeding and acute coagulopathy
is challenging and essential because of the poten-
tial therapeutic implications. Conventional coagula-
tion laboratory tests need time to be performed.
Thromboelastographic assays have been recently
highlighted as an alternative option to detect acute
coagulopathy shortly after trauma and their results
are quickly available.[25,26] Prehospital use of
point-of-care thromboelastographic analyses could
be proposed but studies are needed to determine
its impact [27] and its feasibility.[28] Prehospital
recognition of coagulopathy in trauma patients
could be performed using prehospital clinical
scores like COAST [16] or TICCS.[17]
. . .and treat it with specific actions. . .
A prehospital detection of the early acute coagul-
opathy following severe trauma could lead to
potential-specific therapeutic actions. Several stud-
ies demonstrated that severe trauma patients bene-
fit from an early administration of an antifibrinolytic
agent, like tranexamic acid.[29,30] The MATTERs
study investigators went further by suggesting the
association of a fibrinogen supplementation ther-
apy (with cryoprecipitate) to the antifibrinolytic
therapy and demonstrated a better outcome when
the combined therapy was applied.[31]
Future directions. . .
Rapid Endovascular Balloon Occlusion of the Aorta
REBOA has been recently suggested in the























prehospital setting and could be studied as a
potential part of our therapeutic
armamentarium.[32–34]
Other novel methods of prehospital hemostasis
in extreme circumstances are being explored.
These include intraperitoneal injection of self-
expanding polyurethane polymer foam for non-
compressible massive hemorrhage as well as pre-
hospital thoracotomy, although these methods are
as yet of unproven efficacy.[35–37]
The on-going ‘‘FI in TIC’’ study will evaluate
whether the prehospital pro-coagulant treatment
with fibrinogen concentrate would improve plas-
matic coagulation capacity in severe bleeding
trauma [38] but until now there is no evidence
encouraging the use of fibrinogen concentrate in
massive bleeding. Regarding the prehospital
administration of Prothrombin Complex
Concentrate in the absence of a vitamin K antagon-
ist therapy, data are still lacking.[39]
Conclusion
The first hour following a major trauma with mas-
sive bleeding is certainly the most decisive period
in global trauma care. Depending of the context,
most of it sometimes takes place in the prehospital
setting where many of the needed supplies in
terms of diagnosis, human resources, and treat-
ment options are currently lacking in most trauma
systems. But, far from being a loss of time, those
precious minutes can be used by both the preho-
spital caregivers and the receiving hospital to initi-
ate diagnosis and therapies that will have a
significant positive impact on patient’s outcome.
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